Cargando…

The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review

BACKGROUND: At least 10-20% of the patients suffering from depression meet criteria for treatment-resistant depression (TRD). In the last decades, an important role of glutamate in mood modulation has been hypothesized and ketamine, a non noncompetitive antagonist of the N-methyl-D-aspartate (NMDA)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Serafini, Gianluca, Howland, Robert H, Rovedi, Fabiana, Girardi, Paolo, Amore, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243034/ https://www.ncbi.nlm.nih.gov/pubmed/25426012 http://dx.doi.org/10.2174/1570159X12666140619204251

Ejemplares similares

The Efficacy of Buprenorphine in Major Depression, Treatment-Resistant Depression and Suicidal Behavior: A Systematic Review
por: Serafini, Gianluca, et al.
Publicado: (2018)

The Role of Neuropeptides in Suicidal Behavior: A Systematic Review
por: Serafini, Gianluca, et al.
Publicado: (2013)

Understanding Suicidal Behavior: The Contribution of Recent Resting-State fMRI Techniques
por: Serafini, Gianluca, et al.
Publicado: (2016)

The Association between Cannabis Use, Mental Illness, and Suicidal Behavior: What is the Role of Hopelessness?
por: Serafini, Gianluca, et al.
Publicado: (2013)

Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review
por: Kwaśny, Aleksander, et al.
Publicado: (2023)

Esketamine/ketamine for treatment-resistant depression
por: Lacerda, Acioly L.T.
Publicado: (2020)

The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
por: Hashimoto, Kenji
Publicado: (2014)

Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression
por: Kopelman, Jared, et al.
Publicado: (2023)

Role of the Pharmacist in Managing Treatment-Resistant Depression: A Focus on Ketamine
por: Liu, Linda Xing Yu, et al.
Publicado: (2021)

Clinical Efficacy of Ketamine for Treatment-resistant Depression
por: Bratsos, Sosipatros, et al.
Publicado: (2019)

Magnesium in Ketamine Administration in Treatment-Resistant Depression
por: Górska, Natalia, et al.
Publicado: (2021)

The Role of Ketamine in the Treatment of Bipolar Depression: A Scoping Review
por: Jawad, Muhammad Youshay, et al.
Publicado: (2023)

Ketamine treatment for depression: a review
por: Yavi, Mani, et al.
Publicado: (2022)

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
por: Gałuszko-Węgielnik, Maria, et al.
Publicado: (2023)

Glycosides, Depression and Suicidal Behaviour: The Role of Glycoside-Linked Proteins
por: Serafini, Gianluca, et al.
Publicado: (2011)

Subcutaneous Ketamine in Depression: A Systematic Review
por: Cavenaghi, Vitor Breseghello, et al.
Publicado: (2021)

Ketamine for Bipolar Depression: A Systematic Review
por: Bahji, Anees, et al.
Publicado: (2021)

Ketamine for bipolar depression: an updated systematic review
por: Fancy, Farhan, et al.
Publicado: (2023)

One-Year Outcomes Following Intravenous Ketamine Plus Digital Training Among Patients with Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial
por: Price, Rebecca B., et al.
Publicado: (2023)

Ketamine for the treatment of major depression: a systematic review and meta-analysis
por: Nikolin, Stevan, et al.
Publicado: (2023)

Copper Concentrations in Ketamine Therapy for Treatment-Resistant Depression
por: Słupski, Jakub, et al.
Publicado: (2020)

Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression
por: Rivas-Grajales, Ana Maria, et al.
Publicado: (2020)

How effective are ketamine or esketamine in treatment-resistant depression?
por: Veluri, N., et al.
Publicado: (2021)

The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine
por: Wilkowska, Alina, et al.
Publicado: (2022)

MicroRNAs: fundamental regulators of gene expression in major affective disorders and suicidal behavior?
por: Serafini, Gianluca, et al.
Publicado: (2013)

Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview
por: Pompili, Maurizio, et al.
Publicado: (2016)

White matter hyperintensities and self-reported depression in a sample of patients with chronic headache
por: Serafini, Gianluca, et al.
Publicado: (2012)

The Relation between Persistent Post-Traumatic Headache and PTSD: Similarities and Possible Differences
por: Guglielmetti, Martina, et al.
Publicado: (2020)

Antidepressant Effect of Ketamine on Inflammation-Mediated Cytokine Dysregulation in Adults with Treatment-Resistant Depression: Rapid Systematic Review
por: Sukhram, Shiryn D., et al.
Publicado: (2022)

Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
por: McMullen, Eric P., et al.
Publicado: (2021)

Hippocampal subfield volumes in treatment resistant depression and serial ketamine treatment
por: Zavaliangos-Petropulu, Artemis, et al.
Publicado: (2023)

Commentary on the study of Roy et al. Amygdala Based Altered mir-128-3p in Conferring Susceptibility to Depression-like Behavior via Wnt Signalling
por: Serafini, Gianluca, et al.
Publicado: (2020)

Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review
por: Veraart, Jolien K E, et al.
Publicado: (2021)

Atypical Antipsychotics in the Treatment of Depressive and Psychotic Symptoms in Patients with Chronic Schizophrenia: A Naturalistic Study
por: Innamorati, Marco, et al.
Publicado: (2013)

Efficacy and safety of ketamine for the treatment of depressive symptoms in palliative care: a systematic review
por: Barbosa, Matheus Ghossain, et al.
Publicado: (2023)

Neurocognitive effects of repeated ketamine infusion treatments in patients with treatment resistant depression: a retrospective chart review
por: Dai, Danika, et al.
Publicado: (2022)

Ketamine and Other Glutamate Receptor Modulating Agents for Treatment-Resistant Depression: A Systematic Review of Randomized Controlled Trials
por: Shamabadi, Ahmad, et al.
Publicado: (2022)

Partial Androgen Deficiency, Depression, and Testosterone Supplementation in Aging Men
por: Amore, Mario, et al.
Publicado: (2012)

Recent Stressful Life Events in Euthymic Major Depressive Disorder Patients: Sociodemographic and Clinical Characteristics
por: Serafini, Gianluca, et al.
Publicado: (2020)

Efficacy of ketamine therapy in the treatment of depression
por: Mandal, Suprio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l17r6crc7bgchg3cv38jeq36sc